Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells

P22PRG1/IEX-1 is a putative NF-kappaB target gene implicated in the regulation of cellular viability. Here, we show that in HeLa cells TNFalpha induces expression of p22PRG1/IEX-1 in an NF-kappaB dependent fashion. Blockade of NF-kappaB activation by various NF-kappaB inhibitors abolished TNFalpha-i...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Oncogene 2001-01, Vol.20 (1), p.69-76
Hauptverfasser: Arlt, A, Grobe, O, Sieke, A, Kruse, M L, Fölsch, U R, Schmidt, W E, Schäfer, H
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 76
container_issue 1
container_start_page 69
container_title Oncogene
container_volume 20
creator Arlt, A
Grobe, O
Sieke, A
Kruse, M L
Fölsch, U R
Schmidt, W E
Schäfer, H
description P22PRG1/IEX-1 is a putative NF-kappaB target gene implicated in the regulation of cellular viability. Here, we show that in HeLa cells TNFalpha induces expression of p22PRG1/IEX-1 in an NF-kappaB dependent fashion. Blockade of NF-kappaB activation by various NF-kappaB inhibitors abolished TNFalpha-induced p22PRG1/IEX-1 expression and increased the sensitivity to apoptosis induced by TNFalpha, an activating Fas-antibody or the anti-cancer drug etoposide. Surprisingly, ectopic expression of p22PRG1/IEX-1 in HeLa cells transfected with an inducible p22PRG1/IEX-1-expression vector augments the susceptibility to apoptosis initiated by death-receptor ligands or by etoposide. In addition, p22PRG1/IEX-1 expressing HeLa cells exhibit an accelerated progression through the cell cycle. Transfection of an antisense hammerhead ribozyme targeted to p22PRG1/IEX-1 reduced the speed in cell cycle progression and decreased the apoptotic response to death ligands. Our data demonstrate that p22PRG1/IEX-1 is specifically induced during NF-kappaB activation, but this seems not to be related to the anti-apoptotic actions of NF-kappaB. Instead, NF-kappaB dependent recruitment of p22PRG1/IEX-1 might be related to a modulation in the cell cycle, and hereby, p22PRG1/IEX-1 may accelerate cell growth on the one hand, but may trigger apoptosis on the other. Oncogene (2001) 20, 69 - 76.
doi_str_mv 10.1038/sj.onc.1204061
format Article
fullrecord <record><control><sourceid>gale_proqu</sourceid><recordid>TN_cdi_proquest_miscellaneous_76960283</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><galeid>A205644965</galeid><sourcerecordid>A205644965</sourcerecordid><originalsourceid>FETCH-LOGICAL-c429t-c1c02c9cb9e3030a6b9a5331d5b035759d7cc1187f80c46ab1075b42c0631df63</originalsourceid><addsrcrecordid>eNqFkc1rFEEQxRsxmE306lEaBImH2VR_zvQxhs0HBBVR8Nb09NRMZp2dnnT3hnj1L3c2WfASkDoUVP3e48Ej5C2DJQNRnab1Mox-yThI0OwFWTBZ6kIpI1-SBRgFheGCH5KjlNYAUBrgr8ghY1xKBWpB_qwepogp9WGkoaX5Funni-KXmyZHP9HsYoeZdjgivV79LBg9mTg__frtkn2kTcBEx5DpbHCPY6Yeh4E26PItrbeZ9mPK6BqaY991GBN1U5hySH2aX_QKB_eoSK_JQeuGhG_2-5j8uFh9P78qbr5cXp-f3RRecpMLzzxwb3xtUIAAp2vjlBCsUTUIVSrTlN4zVpVtBV5qVzMoVS25Bz1DrRbH5MOT7xTD3RZTtps-7RK4EcM22VIbDbwS_wVZWSkjmJrB909g5wa0_diGHJ3fwfaMg9JSGr2jls9Q8zS46X0Yse3n-3MCH0NKEVs7xX7j4m_LwO5at2lt59btvvVZ8G4feFtvsPmH72sWfwGc86WU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>17859315</pqid></control><display><type>article</type><title>Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells</title><source>MEDLINE</source><source>Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals</source><source>Springer Nature - Complete Springer Journals</source><source>Nature Journals Online</source><creator>Arlt, A ; Grobe, O ; Sieke, A ; Kruse, M L ; Fölsch, U R ; Schmidt, W E ; Schäfer, H</creator><creatorcontrib>Arlt, A ; Grobe, O ; Sieke, A ; Kruse, M L ; Fölsch, U R ; Schmidt, W E ; Schäfer, H</creatorcontrib><description>P22PRG1/IEX-1 is a putative NF-kappaB target gene implicated in the regulation of cellular viability. Here, we show that in HeLa cells TNFalpha induces expression of p22PRG1/IEX-1 in an NF-kappaB dependent fashion. Blockade of NF-kappaB activation by various NF-kappaB inhibitors abolished TNFalpha-induced p22PRG1/IEX-1 expression and increased the sensitivity to apoptosis induced by TNFalpha, an activating Fas-antibody or the anti-cancer drug etoposide. Surprisingly, ectopic expression of p22PRG1/IEX-1 in HeLa cells transfected with an inducible p22PRG1/IEX-1-expression vector augments the susceptibility to apoptosis initiated by death-receptor ligands or by etoposide. In addition, p22PRG1/IEX-1 expressing HeLa cells exhibit an accelerated progression through the cell cycle. Transfection of an antisense hammerhead ribozyme targeted to p22PRG1/IEX-1 reduced the speed in cell cycle progression and decreased the apoptotic response to death ligands. Our data demonstrate that p22PRG1/IEX-1 is specifically induced during NF-kappaB activation, but this seems not to be related to the anti-apoptotic actions of NF-kappaB. Instead, NF-kappaB dependent recruitment of p22PRG1/IEX-1 might be related to a modulation in the cell cycle, and hereby, p22PRG1/IEX-1 may accelerate cell growth on the one hand, but may trigger apoptosis on the other. Oncogene (2001) 20, 69 - 76.</description><identifier>ISSN: 0950-9232</identifier><identifier>EISSN: 1476-5594</identifier><identifier>DOI: 10.1038/sj.onc.1204061</identifier><identifier>PMID: 11244505</identifier><language>eng</language><publisher>England: Nature Publishing Group</publisher><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacology ; Antineoplastic Agents - pharmacology ; Apoptosis ; Apoptosis - drug effects ; Apoptosis - genetics ; Apoptosis Regulatory Proteins ; Biochemistry ; Catalytic RNA ; Cell Cycle - drug effects ; Cell Cycle - genetics ; Cell Death - genetics ; Etoposide ; Genetic Vectors - metabolism ; Gliotoxin - pharmacology ; HeLa Cells - cytology ; HeLa Cells - drug effects ; HeLa Cells - metabolism ; Humans ; Hydrolysis ; IEX-1 gene ; Immediate-Early Proteins - biosynthesis ; Immediate-Early Proteins - genetics ; Immediate-Early Proteins - metabolism ; Immediate-Early Proteins - physiology ; Immunosuppressive Agents - pharmacology ; Leucine - analogs &amp; derivatives ; Leucine - pharmacology ; Leupeptins - pharmacology ; Membrane Glycoproteins - biosynthesis ; Membrane Glycoproteins - genetics ; Membrane Glycoproteins - metabolism ; Membrane Glycoproteins - physiology ; Membrane Proteins ; Neoplasm Proteins ; NF-kappa B - antagonists &amp; inhibitors ; NF-kappa B - metabolism ; NF-kappa B - physiology ; RNA, Catalytic - metabolism ; Sulfasalazine - pharmacology ; Tetracycline - pharmacology ; Transfection ; Tumor necrosis factor ; Tumor Necrosis Factor-alpha - pharmacology ; Tumor Necrosis Factor-alpha - physiology</subject><ispartof>Oncogene, 2001-01, Vol.20 (1), p.69-76</ispartof><rights>COPYRIGHT 2001 Nature Publishing Group</rights><lds50>peer_reviewed</lds50><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c429t-c1c02c9cb9e3030a6b9a5331d5b035759d7cc1187f80c46ab1075b42c0631df63</citedby><cites>FETCH-LOGICAL-c429t-c1c02c9cb9e3030a6b9a5331d5b035759d7cc1187f80c46ab1075b42c0631df63</cites></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,776,780,27903,27904</link.rule.ids><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/11244505$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>Arlt, A</creatorcontrib><creatorcontrib>Grobe, O</creatorcontrib><creatorcontrib>Sieke, A</creatorcontrib><creatorcontrib>Kruse, M L</creatorcontrib><creatorcontrib>Fölsch, U R</creatorcontrib><creatorcontrib>Schmidt, W E</creatorcontrib><creatorcontrib>Schäfer, H</creatorcontrib><title>Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells</title><title>Oncogene</title><addtitle>Oncogene</addtitle><description>P22PRG1/IEX-1 is a putative NF-kappaB target gene implicated in the regulation of cellular viability. Here, we show that in HeLa cells TNFalpha induces expression of p22PRG1/IEX-1 in an NF-kappaB dependent fashion. Blockade of NF-kappaB activation by various NF-kappaB inhibitors abolished TNFalpha-induced p22PRG1/IEX-1 expression and increased the sensitivity to apoptosis induced by TNFalpha, an activating Fas-antibody or the anti-cancer drug etoposide. Surprisingly, ectopic expression of p22PRG1/IEX-1 in HeLa cells transfected with an inducible p22PRG1/IEX-1-expression vector augments the susceptibility to apoptosis initiated by death-receptor ligands or by etoposide. In addition, p22PRG1/IEX-1 expressing HeLa cells exhibit an accelerated progression through the cell cycle. Transfection of an antisense hammerhead ribozyme targeted to p22PRG1/IEX-1 reduced the speed in cell cycle progression and decreased the apoptotic response to death ligands. Our data demonstrate that p22PRG1/IEX-1 is specifically induced during NF-kappaB activation, but this seems not to be related to the anti-apoptotic actions of NF-kappaB. Instead, NF-kappaB dependent recruitment of p22PRG1/IEX-1 might be related to a modulation in the cell cycle, and hereby, p22PRG1/IEX-1 may accelerate cell growth on the one hand, but may trigger apoptosis on the other. Oncogene (2001) 20, 69 - 76.</description><subject>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</subject><subject>Antineoplastic Agents - pharmacology</subject><subject>Apoptosis</subject><subject>Apoptosis - drug effects</subject><subject>Apoptosis - genetics</subject><subject>Apoptosis Regulatory Proteins</subject><subject>Biochemistry</subject><subject>Catalytic RNA</subject><subject>Cell Cycle - drug effects</subject><subject>Cell Cycle - genetics</subject><subject>Cell Death - genetics</subject><subject>Etoposide</subject><subject>Genetic Vectors - metabolism</subject><subject>Gliotoxin - pharmacology</subject><subject>HeLa Cells - cytology</subject><subject>HeLa Cells - drug effects</subject><subject>HeLa Cells - metabolism</subject><subject>Humans</subject><subject>Hydrolysis</subject><subject>IEX-1 gene</subject><subject>Immediate-Early Proteins - biosynthesis</subject><subject>Immediate-Early Proteins - genetics</subject><subject>Immediate-Early Proteins - metabolism</subject><subject>Immediate-Early Proteins - physiology</subject><subject>Immunosuppressive Agents - pharmacology</subject><subject>Leucine - analogs &amp; derivatives</subject><subject>Leucine - pharmacology</subject><subject>Leupeptins - pharmacology</subject><subject>Membrane Glycoproteins - biosynthesis</subject><subject>Membrane Glycoproteins - genetics</subject><subject>Membrane Glycoproteins - metabolism</subject><subject>Membrane Glycoproteins - physiology</subject><subject>Membrane Proteins</subject><subject>Neoplasm Proteins</subject><subject>NF-kappa B - antagonists &amp; inhibitors</subject><subject>NF-kappa B - metabolism</subject><subject>NF-kappa B - physiology</subject><subject>RNA, Catalytic - metabolism</subject><subject>Sulfasalazine - pharmacology</subject><subject>Tetracycline - pharmacology</subject><subject>Transfection</subject><subject>Tumor necrosis factor</subject><subject>Tumor Necrosis Factor-alpha - pharmacology</subject><subject>Tumor Necrosis Factor-alpha - physiology</subject><issn>0950-9232</issn><issn>1476-5594</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2001</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNqFkc1rFEEQxRsxmE306lEaBImH2VR_zvQxhs0HBBVR8Nb09NRMZp2dnnT3hnj1L3c2WfASkDoUVP3e48Ej5C2DJQNRnab1Mox-yThI0OwFWTBZ6kIpI1-SBRgFheGCH5KjlNYAUBrgr8ghY1xKBWpB_qwepogp9WGkoaX5Funni-KXmyZHP9HsYoeZdjgivV79LBg9mTg__frtkn2kTcBEx5DpbHCPY6Yeh4E26PItrbeZ9mPK6BqaY991GBN1U5hySH2aX_QKB_eoSK_JQeuGhG_2-5j8uFh9P78qbr5cXp-f3RRecpMLzzxwb3xtUIAAp2vjlBCsUTUIVSrTlN4zVpVtBV5qVzMoVS25Bz1DrRbH5MOT7xTD3RZTtps-7RK4EcM22VIbDbwS_wVZWSkjmJrB909g5wa0_diGHJ3fwfaMg9JSGr2jls9Q8zS46X0Yse3n-3MCH0NKEVs7xX7j4m_LwO5at2lt59btvvVZ8G4feFtvsPmH72sWfwGc86WU</recordid><startdate>20010104</startdate><enddate>20010104</enddate><creator>Arlt, A</creator><creator>Grobe, O</creator><creator>Sieke, A</creator><creator>Kruse, M L</creator><creator>Fölsch, U R</creator><creator>Schmidt, W E</creator><creator>Schäfer, H</creator><general>Nature Publishing Group</general><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope><scope>AAYXX</scope><scope>CITATION</scope><scope>7TO</scope><scope>H94</scope><scope>7X8</scope></search><sort><creationdate>20010104</creationdate><title>Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells</title><author>Arlt, A ; Grobe, O ; Sieke, A ; Kruse, M L ; Fölsch, U R ; Schmidt, W E ; Schäfer, H</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c429t-c1c02c9cb9e3030a6b9a5331d5b035759d7cc1187f80c46ab1075b42c0631df63</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2001</creationdate><topic>Anti-Inflammatory Agents, Non-Steroidal - pharmacology</topic><topic>Antineoplastic Agents - pharmacology</topic><topic>Apoptosis</topic><topic>Apoptosis - drug effects</topic><topic>Apoptosis - genetics</topic><topic>Apoptosis Regulatory Proteins</topic><topic>Biochemistry</topic><topic>Catalytic RNA</topic><topic>Cell Cycle - drug effects</topic><topic>Cell Cycle - genetics</topic><topic>Cell Death - genetics</topic><topic>Etoposide</topic><topic>Genetic Vectors - metabolism</topic><topic>Gliotoxin - pharmacology</topic><topic>HeLa Cells - cytology</topic><topic>HeLa Cells - drug effects</topic><topic>HeLa Cells - metabolism</topic><topic>Humans</topic><topic>Hydrolysis</topic><topic>IEX-1 gene</topic><topic>Immediate-Early Proteins - biosynthesis</topic><topic>Immediate-Early Proteins - genetics</topic><topic>Immediate-Early Proteins - metabolism</topic><topic>Immediate-Early Proteins - physiology</topic><topic>Immunosuppressive Agents - pharmacology</topic><topic>Leucine - analogs &amp; derivatives</topic><topic>Leucine - pharmacology</topic><topic>Leupeptins - pharmacology</topic><topic>Membrane Glycoproteins - biosynthesis</topic><topic>Membrane Glycoproteins - genetics</topic><topic>Membrane Glycoproteins - metabolism</topic><topic>Membrane Glycoproteins - physiology</topic><topic>Membrane Proteins</topic><topic>Neoplasm Proteins</topic><topic>NF-kappa B - antagonists &amp; inhibitors</topic><topic>NF-kappa B - metabolism</topic><topic>NF-kappa B - physiology</topic><topic>RNA, Catalytic - metabolism</topic><topic>Sulfasalazine - pharmacology</topic><topic>Tetracycline - pharmacology</topic><topic>Transfection</topic><topic>Tumor necrosis factor</topic><topic>Tumor Necrosis Factor-alpha - pharmacology</topic><topic>Tumor Necrosis Factor-alpha - physiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Arlt, A</creatorcontrib><creatorcontrib>Grobe, O</creatorcontrib><creatorcontrib>Sieke, A</creatorcontrib><creatorcontrib>Kruse, M L</creatorcontrib><creatorcontrib>Fölsch, U R</creatorcontrib><creatorcontrib>Schmidt, W E</creatorcontrib><creatorcontrib>Schäfer, H</creatorcontrib><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><collection>CrossRef</collection><collection>Oncogenes and Growth Factors Abstracts</collection><collection>AIDS and Cancer Research Abstracts</collection><collection>MEDLINE - Academic</collection><jtitle>Oncogene</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Arlt, A</au><au>Grobe, O</au><au>Sieke, A</au><au>Kruse, M L</au><au>Fölsch, U R</au><au>Schmidt, W E</au><au>Schäfer, H</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells</atitle><jtitle>Oncogene</jtitle><addtitle>Oncogene</addtitle><date>2001-01-04</date><risdate>2001</risdate><volume>20</volume><issue>1</issue><spage>69</spage><epage>76</epage><pages>69-76</pages><issn>0950-9232</issn><eissn>1476-5594</eissn><abstract>P22PRG1/IEX-1 is a putative NF-kappaB target gene implicated in the regulation of cellular viability. Here, we show that in HeLa cells TNFalpha induces expression of p22PRG1/IEX-1 in an NF-kappaB dependent fashion. Blockade of NF-kappaB activation by various NF-kappaB inhibitors abolished TNFalpha-induced p22PRG1/IEX-1 expression and increased the sensitivity to apoptosis induced by TNFalpha, an activating Fas-antibody or the anti-cancer drug etoposide. Surprisingly, ectopic expression of p22PRG1/IEX-1 in HeLa cells transfected with an inducible p22PRG1/IEX-1-expression vector augments the susceptibility to apoptosis initiated by death-receptor ligands or by etoposide. In addition, p22PRG1/IEX-1 expressing HeLa cells exhibit an accelerated progression through the cell cycle. Transfection of an antisense hammerhead ribozyme targeted to p22PRG1/IEX-1 reduced the speed in cell cycle progression and decreased the apoptotic response to death ligands. Our data demonstrate that p22PRG1/IEX-1 is specifically induced during NF-kappaB activation, but this seems not to be related to the anti-apoptotic actions of NF-kappaB. Instead, NF-kappaB dependent recruitment of p22PRG1/IEX-1 might be related to a modulation in the cell cycle, and hereby, p22PRG1/IEX-1 may accelerate cell growth on the one hand, but may trigger apoptosis on the other. Oncogene (2001) 20, 69 - 76.</abstract><cop>England</cop><pub>Nature Publishing Group</pub><pmid>11244505</pmid><doi>10.1038/sj.onc.1204061</doi><tpages>8</tpages><oa>free_for_read</oa></addata></record>
fulltext fulltext
identifier ISSN: 0950-9232
ispartof Oncogene, 2001-01, Vol.20 (1), p.69-76
issn 0950-9232
1476-5594
language eng
recordid cdi_proquest_miscellaneous_76960283
source MEDLINE; Elektronische Zeitschriftenbibliothek - Frei zugängliche E-Journals; Springer Nature - Complete Springer Journals; Nature Journals Online
subjects Anti-Inflammatory Agents, Non-Steroidal - pharmacology
Antineoplastic Agents - pharmacology
Apoptosis
Apoptosis - drug effects
Apoptosis - genetics
Apoptosis Regulatory Proteins
Biochemistry
Catalytic RNA
Cell Cycle - drug effects
Cell Cycle - genetics
Cell Death - genetics
Etoposide
Genetic Vectors - metabolism
Gliotoxin - pharmacology
HeLa Cells - cytology
HeLa Cells - drug effects
HeLa Cells - metabolism
Humans
Hydrolysis
IEX-1 gene
Immediate-Early Proteins - biosynthesis
Immediate-Early Proteins - genetics
Immediate-Early Proteins - metabolism
Immediate-Early Proteins - physiology
Immunosuppressive Agents - pharmacology
Leucine - analogs & derivatives
Leucine - pharmacology
Leupeptins - pharmacology
Membrane Glycoproteins - biosynthesis
Membrane Glycoproteins - genetics
Membrane Glycoproteins - metabolism
Membrane Glycoproteins - physiology
Membrane Proteins
Neoplasm Proteins
NF-kappa B - antagonists & inhibitors
NF-kappa B - metabolism
NF-kappa B - physiology
RNA, Catalytic - metabolism
Sulfasalazine - pharmacology
Tetracycline - pharmacology
Transfection
Tumor necrosis factor
Tumor Necrosis Factor-alpha - pharmacology
Tumor Necrosis Factor-alpha - physiology
title Expression of the NF-kappa B target gene IEX-1 (p22/PRG1) does not prevent cell death but instead triggers apoptosis in Hela cells
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-21T10%3A55%3A03IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-gale_proqu&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Expression%20of%20the%20NF-kappa%20B%20target%20gene%20IEX-1%20(p22/PRG1)%20does%20not%20prevent%20cell%20death%20but%20instead%20triggers%20apoptosis%20in%20Hela%20cells&rft.jtitle=Oncogene&rft.au=Arlt,%20A&rft.date=2001-01-04&rft.volume=20&rft.issue=1&rft.spage=69&rft.epage=76&rft.pages=69-76&rft.issn=0950-9232&rft.eissn=1476-5594&rft_id=info:doi/10.1038/sj.onc.1204061&rft_dat=%3Cgale_proqu%3EA205644965%3C/gale_proqu%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=17859315&rft_id=info:pmid/11244505&rft_galeid=A205644965&rfr_iscdi=true